Inventive Biomaterials for Tissue Engineering and Drug Delivery Applications

Dear Colleagues,

Biomaterial plays a central element for tissue engineering (TE). TE is a promising and advancing field that plays a major role in restoring of damaged tissue by merging cells with biomaterials that can act as a template for the regeneration of tissues and organs. TE is a highly multidisciplinary field that includes different areas, including material science, clinical medicine, mechanical engineering, genetics, drug delivery, cell culture, and other disciplines related to life sciences and engineering. The TE field is mainly based on the use of biomimetic materials (in different forms such as scaffolds, hydrogels etc.) that provide both suitable environment for the development of new tissue and base for cell adhesion, proliferation, and new tissue formation. In recent years, even the natural and synthetic biomaterials have become very important basics for the TE and regenerative medicine strategies. Emerging fields of 3D bioprinting technology use biomaterials in a precise spatial arrangement way to fabricate 3D cellularized constructs for invitro models, therapeutics, and drug delivery applications.

The goal of this Special Issue is to cover current advances and promising developments in the design and development of biomaterials for tissue engineering and organ development, including biomaterials, hydrogels, bioactive materials, composites, biodegradable  polymers, nanofibers, and microfibers. Biomaterials for in vitro and in vivo studies, biocompatibility, drug delivery, wound healing, bone healing, vascular tissue engineering, organs, and other products for the clinical application in the restoration of damaged tissue or organs will be discussed.

Dr. Muthukumar Thangavelu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.